We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
REVIEW
[Gait and dual-task: definition, interest, and perspectives in the elderly].
Psychologie & Neuropsychiatrie du Vieillissement 2006 September
Walking is an automated rythmic motor behavior that is mostly controlled by subcortical brain regions. Automaticity implies that gait can be performed without attention. However, recent works highlight the involvement of attentional resources in gait, using a "dual-task" methodology in which performance on attention-demanding tasks such as spoken verbal response and walking is compared when they are performed separately and concurrently. Changes in gait patterns due to simultaneous performance of an attention-demanding task are interpreted as interference caused by competing demands for attentional resources involving the cortical level in gait control. Dual-task related gait changes are a new way to assess age-associated change in gait control. Furthermore, new screening tools of falling risk based on the dual-task paradigm have been developed, comparing walking performance alone to walking while performing a simultaneous attention-demanding task. However, the consistent prediction of falls by dual-task testing remains difficult. The recent availability and growing number of validated, user-friendly portable gait analysis systems allow simple objective gait measurement such as gait variability. The study of gait variability under dual-task represents a new challenge for the clinicians because high stride-to-stride variability is a powerful fall predictor in older adults. Because there is increasing evidence that age-related gait changes are associated with incidence of dementia, dual-task related gait changes could provide useful information about relationship between gait disorders and cognitive decline. Furthermore, dual-task could be a new approach of the gait disorders rehabilitation.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app